(Q40546965)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15190257%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

Proteasome inhibitor, bortezomib, potently inhibits the growth of adult T-cell leukemia cells both in vivo and in vitro (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15190257%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15190257%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Masao Matsuoka

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15190257%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Jun-ichirou Yasunaga

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15190257%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Shinya Toyokuni

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15190257%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Nosaka K

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15190257%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Koya Y

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15190257%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 August 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15190257%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15190257%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15190257%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15190257%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

1357-1363

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15190257%20AND%20SRC:MED&resulttype=core&format=json

A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303.

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403400

Impaired production of naive T lymphocytes in human T-cell leukemia virus type I-infected individuals: its implications in the immunodeficient state

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403400

Multiple viral strategies of HTLV-1 for dysregulation of cell growth control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403400

Functional activities of the human T-cell leukemia virus type I Tax oncoprotein: cellular signaling through NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403400

Kappa B-specific DNA binding proteins: role in the regulation of human interleukin-2 gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403400

The proteasome: a novel target for cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403400

A phase 2 study of bortezomib in relapsed, refractory myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403400

Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403400

Genetic and epigenetic inactivation of tax gene in adult T-cell leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403400

A novel mechanism for imatinib mesylate-induced cell death of BCR-ABL-positive human leukemic cells: caspase-independent, necrosis-like programmed cell death mediated by serine protease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403400

Inhibition of apoptosis in T cells expressing human T cell leukemia virus type I Tax.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403400

Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403400

Role of Adapter Function in Oncoprotein-mediated Activation of NF-κB

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403400

Caspase-independent cell death in T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403400

Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403400

Necrotic death pathway in Fas receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403400

Inhibition of NFkappaB induces caspase-independent cell death in human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403400

Activation of NF-kappa B requires proteolysis of the inhibitor I kappa B-alpha: signal-induced phosphorylation of I kappa B-alpha alone does not release active NF-kappa B

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403400

21 January 2018

Identifiers

DOI

10.1038/SJ.LEU.2403400

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15190257%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

29 December 2019

1000060150

0 references

1 reference